Company / Operating Cash Flow
Co-Diagnostics, Inc. Operating Cash Flow History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$29.1M
FY2025
5-year range
-$29.2M / $41.1M
FY2021-FY2025
Trend
+0.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow returned to growth in FY2025 after 2 years of decline, reaching -$29M.
Based on SEC 10-K filings.
-$29M in FY2025.
Declined from -$22M to -$29M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow increased 0.1% year-over-year.
- Peak operating cash flow was recorded in FY2022.
- Lowest operating cash flow in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$29.1M | +0.1% |
| FY2024 | -$29.2M | -32.0% |
| FY2023 | -$22.1M | -153.8% |
| FY2022 | $41.1M | +45.9% |
| FY2021 | $28.2M | +609.8% |
| FY2020 | -$5.5M | -35.4% |
| FY2019 | -$4.1M | -27.0% |
| FY2018 | -$3.2M | -144.7% |
| FY2017 | -$1.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026